CLINICAL_TRIALS
trial_result
· 2021-02-21
Clinical Trial Update: A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers [Phase 2]
Summary
Phase 2 randomized, double-blind placebo-controlled pharmacogenetic study of topiramate in European-American heavy drinkers has completed; results posted in 202…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pennsylvania | Conditions: Alcoholism, Alcohol Use Disorder (AUD) | Phase 2 | Status: COMPLETED | Results posted: 2021-02-21